Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism

Cyclosporine induces cancer progression by a cell-autonomous mechanism

Minoru Hojo, Takashi Morimoto, Mary A. Maluccio et al. · Nature · 1999 · 1.2K citations

Medicine, Oncology, Pharmacology +11

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

David M. Thomas, Robert M. Henshaw, Keith M. Skubitz et al. · The Lancet Oncology · 2010 · 711 citations

Medicine, Oncology, Surgery +12

Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism

Yasuyoshi Ueki, Valdenize Tiziani, Carla Santanna et al. · Nature Genetics · 2001 · 385 citations

Life Sciences, Genetics, Molecular Biology +4

Denosumab treatment for fibrous dysplasia

Alison M. Boyce, William H Chong, Jack Yao et al. · Journal of Bone and Mineral Research · 2012 · 263 citations · Full text

Medicine, Molecular Biology, Orthopaedic Surgery +17

Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism

Noam Levaot, Oleksandr Voytyuk, Ioannis D. Dimitriou et al. · Cell · 2011 · 191 citations · Full text

Life Sciences, Biology, Molecular Biology +2